According to NRx Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -S$32.33 M. In 2023 the company made an earning of -S$39.28 M an increase over its 2022 earnings that were of -S$51.79 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.